Medpace Holdings Inc
MEDP: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$813.00 | Nmknf | Frxffndx |
Medpace Holdings: Healthy Outsourcing Demand Supports Strong Growth; $227 Fair Value Estimate
We have launched coverage of Medpace, a global contract research organization, or CRO. We assign Medpace a fair value estimate of $227 per share and view the stock as fairly valued. It’s currently trading in 3-star territory. We believe Medpace has a narrow economic moat and stable moat trend based on its intangible assets and high switching costs for its customers.